Merck KGaA to acquire Rapid Micro Biosystems; Q3 revenue rises to $9.5M
Rapid Micro Biosystems, maker of the Growth Direct microbial QC system, reported record gross margin and agreed a tender-offer deal with Merck KGaA, Darmstadt, while withdrawing 2026 guidance.
Rapid Micro Biosystems has announced a definitive agreement to be acquired by Merck KGaA, Darmstadt. The deal is to be carried out through a tender offer, which has not yet begun, according to the company's announcement of 16 November 2026.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.
Company's press release (SEC filing): Rapid Micro Biosystems, Inc. ↗
Article written by VigiEye from the official source (Rapid Micro Biosystems, Inc.). Claims are the company's own. AI-assisted; check the source before acting.